Status:
RECRUITING
Screening, Evaluation and Assessment (SEA) Protocol at the NIDA IRP
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Conditions:
Substance Use Disorder
Alcohol Use Disorder
Eligibility:
All Genders
18-99 years
Brief Summary
Background: People who will participate in research studies need to undergo proper screening, evaluation, and assessment (SEA). SEA helps keep those who participate in studies safe. It also helps ens...
Detailed Description
Study Description: This protocol describes the screening and evaluation process used by the National Institute on Drug Abuse (NIDA) Intramural Research Program (IRP) to assess eligibility of individu...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- This protocol is seeking individuals with current or past SUDs and/or AUD, as well as those who have never had an SUD or AUD. These individuals also may or may not be in treatment for their AUD/SUDs.
- To be eligible to participate in this study, an individual must meet the following criteria:
- Age 18-99 years old.
- Proficient ability to read, write, and understand English.
- Stated willingness to comply with all screening procedures and availability for the duration of the screening period
- Ability of subject to understand and the willingness to sign a written informed consent document.
- EXCLUSION CRITERIA:
- Individuals who lack capacity to consent to research participation to this protocol as determined by the Evaluation to Sign Consent (ESC).
Exclusion
Key Trial Info
Start Date :
September 4 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2047
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT06552741
Start Date
September 4 2024
End Date
January 1 2047
Last Update
December 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute on Drug Abuse
Baltimore, Maryland, United States, 21224